This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: The Hospital for Sick Children, University of Toronto. Active years: 2025.
Company Filing History:
1 out of 167 
1 out of 529 
Years Active: 2025
Title: Taylor Sicard: Innovator in Nanoparticle Technology
Introduction
Taylor Sicard is a prominent inventor based in Toronto, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of innovative platforms for antibody and vaccine delivery. His work is characterized by a focus on enhancing the efficacy of therapeutic agents through advanced nanotechnology.
Latest Patents
Taylor Sicard holds a patent for a groundbreaking invention titled "Nanoparticle platform for antibody and vaccine delivery." This patent describes a fusion protein that comprises a nanocage monomer linked to an antibody or a fragment thereof. The design allows for a plurality of these fusion proteins to self-assemble into a nanocage, where the antibodies are strategically positioned on the exterior surface. This configuration enables the first member of a binding pair to interact effectively with a second member, enhancing the delivery and efficacy of vaccines and antibodies.
Career Highlights
Throughout his career, Taylor has worked with esteemed institutions such as the University of Toronto and The Hospital for Sick Children. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical technology.
Collaborations
Taylor has collaborated with notable colleagues, including Anthony Semesi and Tiantian Zhao. These partnerships have fostered a dynamic environment for innovation and have led to the development of cutting-edge solutions in the realm of nanoparticle technology.
Conclusion
In summary, Taylor Sicard is a distinguished inventor whose work in nanoparticle technology is paving the way for advancements in antibody and vaccine delivery systems. His innovative approach and collaborations with leading institutions highlight his commitment to improving healthcare through scientific innovation.